Impact of administration route on nanocarrier biodistribution in a murine colitis model

References

• Alatab S, Sepanlou SG, Ikuta K, et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2020;1:17–30.
   Google Scholar
• Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;7351:307–317.
   Google Scholar
• Singh UP, Singh NP, Murphy EA, et al. Chemokine and cytokine levels in inflammatory bowel disease patients. Cytokine. 2016;77:44–49.
   Google Scholar
• Műzes G, Molnár B, Tulassay Z, et al. Changes of the cytokine profile in inflammatory bowel diseases. World J Gastroenterol. 2012;41:5848–5861.
   Google Scholar
• Schiavone C, Romano M. Diagnosis and management of Crohn’s disease. J Ultrasound. 2015;1:1–2.
   Google Scholar
• Cherry SR. Fundamentals of positron emission tomography and applications in preclinical drug development. J Clin Pharmacol. 2001;41(5):482–491.
   Google Scholar
• Kung BT, Seraj SM, Zadeh MZ, et al. An update on the role of (18)F-Fdg-Pet/Ct in major infectious and inflammatory diseases. Am J Nucl Med Mol Imaging. 2019;6:255–273.
   Google Scholar
• Basu S, Zhuang H, Torigian DA, et al. Functional imaging of inflammatory diseases using nuclear medicine techniques. Semin Nucl Med. 2009;2:124–145.
   Google Scholar
• Luo Y, Gao C, Chen W, et al. Molecular magnetic resonance imaging with contrast agents for assessment of inflammatory bowel disease: a systematic review. Contrast Media Mol Imaging. 2020;2020:4764985.
   Google Scholar
• Yu Y, Wu Y, Liu J, et al. Ultrasmall dopamine-coated nanogolds: preparation, characteristics, and CT imaging. J Exp Nanosci. 2016;11(sup1):S1–s11.
   Google Scholar
• Sharma R, Kwon S. New applications of nanoparticles in cardiovascular imaging. J Exp Nanosci. 2007;1–2:115–126.
   Google Scholar
• Fedorak RN, Haeberlin B, Empey LR, et al. Colonic delivery of dexamethasone from a prodrug accelerates healing of colitis in rats without adrenal suppression. Gastroenterology. 1995;6:1688–1699.
   Google Scholar
• Huang Z, Gan J, Jia L, et al. An orally administrated nucleotide-delivery vehicle targeting colonic macrophages for the treatment of inflammatory bowel disease. Biomaterials. 2015;48:26–36.
   Google Scholar
• McLeod AD, Friend DR, Tozer TN. Synthesis and chemical stability of glucocorticoid-dextran esters: potential prodrugs for colon-specific delivery. Int J Pharm. 1993;92(1–3):105–114.
   Google Scholar
• Pang YN, Zhang Y, Zhang ZR. Synthesis of an enzyme-dependent prodrug and evaluation of its potential for colon targeting. World J Gastroenterol. 2002;5:913–917.
   Google Scholar
• Varshosaz J, Emami J, Ahmadi F, et al. Preparation of budesonide-dextran conjugates using glutarate spacer as a colon-targeted drug delivery system: in vitro/in vivo evaluation in induced ulcerative colitis. J Drug Target. 2011;2:140–153.
   Google Scholar
• Wu Y, Briley-Saebo K, Xie J, et al. Inflammatory bowel disease: MR- and SPECT/CT-based macrophage imaging for monitoring and evaluating disease activity in experimental mouse model–pilot study. Radiology. 2014;2:400–407.
   Google Scholar
• Sharma A, Cornejo C, Mihalic J, et al. Physical characterization and in vivo organ distribution of coated iron oxide nanoparticles. Sci Rep. 2018;8(1):4916.
   Google Scholar
• Shannahan J. The biocorona: a challenge for the biomedical application of nanoparticles. Nanotechnol Rev. 2017;6(4):345–353.
   Google Scholar
• Zhang-Hong H, Yiang L, Liang Z, et al. Preparation of a novel liver-targeting nanoparticle of norcantharidin derivative and evaluation of its anti-tumour activity. J Exp Nanosci. 2011;2:183–199.
   Google Scholar
• Ma L, Liu TW, Wallig MA, et al. Efficient targeting of adipose tissue macrophages in obesity with polysaccharide nanocarriers. ACS Nano. 2016;7:6952–6962.
   Google Scholar
• Zinderman CE, Landow L, Wise RP. Anaphylactoid reactions to dextran 40 and 70: Reports to the United States food and drug administration, 1969 to 2004. J Vascular Surg. 2006;5:1004–1009.
   Google Scholar
• Chassaing B, Aitken JD, Malleshappa M, et al. Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol. 2014;15(25):11–15 25 14.
   Google Scholar
• Perse M, Cerar A. Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol. 2012;2012:718617.
   Google Scholar
• Kim JJ, Shajib MS, Manocha MM, et al. Investigating intestinal inflammation in DSS-induced model of IBD. J Vis Exp. 2012;60:3678.
   Google Scholar
• Pustylnikov S, Sagar D, Jain P, et al. Targeting the C-type lectins-mediated host-pathogen interactions with dextran. J Pharm Pharma Sci. 2014;3:371–392.
   Google Scholar
• Shimaoka T, Kume N, Minami M, et al. Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. J Biol Chem. 2000;52:40663–40666.
   Google Scholar
• Fu J, Wei B, Wen T, et al. Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice. J Clin Invest. 2011;4:1657–1666.
   Google Scholar
• Heazlewood CK, Cook MC, Eri R, et al. Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med. 2008;3:e54.
   Google Scholar
• Swidsinski A, Loening-Baucke V, Theissig F, et al. Comparative study of the intestinal mucus barrier in normal and inflamed colon. Gut. 2007;3:343–350. [Database][Mismatch
   Google Scholar
• Olmsted SS, Padgett JL, Yudin AI, et al. Diffusion of macromolecules and virus-like particles in human cervical mucus. Biophys J. 2001;4:1930–1937.
   Google Scholar
• Lamprecht A, Ubrich N, Yamamoto H, et al. Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. J Pharmacol Exp Therap. 2001;2:775–781.
   Google Scholar
• Hovgaard L, Brøndsted H. Dextran hydrogels for colon-specific drug delivery. J Controll Release. 1995;1:159–166.
   Google Scholar
• Weissleder R, Nahrendorf M, Pittet MJ. Imaging macrophages with nanoparticles. Nat Mater. 2014;13(2):125–138.
   Google Scholar
• Vavricka SR, Schoepfer A, Scharl M, et al. Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2015;8:1982–1992.
   Google Scholar
• Kumar R, Roy I, Ohulchanskky TY, et al. In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano. 2010;2:699–708.
   Google Scholar
• Martinez MN, Amidon GL. A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals. J Clin Pharmacol. 2002;6:620–643.
   Google Scholar
• Haute DV, Berlin JM. Challenges in realizing selectivity for nanoparticle biodistribution and clearance: lessons from gold nanoparticles. Ther Deliv. 2017;8(9):763–774.
   Google Scholar
• Melgar S, Karlsson A, Michaelsson E. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57bl/6 but not in balb/C mice: correlation between symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol. 2005;6:G1328–1338.
   Google Scholar
• Coulie B, Camilleri M, Bharucha AE, et al. Colonic motility in chronic ulcerative proctosigmoiditis and the effects of nicotine on colonic motility in patients and healthy subjects. Aliment Pharmacol Ther. 2001;5:653–663.
   Google Scholar
• Larsen C, Jensen BH, Olesen HP. Bioavailability of ketoprofen from orally administered ketoprofen-dextran ester prodrugs in the pig. Acta Pharma Nor. 1991;2:71–76.
   Google Scholar
• Osterman MT. Mucosal healing in inflammatory bowel disease. J Clin Gastroenterol. 2013;47(3):212–221.
   Google Scholar
• Kilcoyne A, Kaplan JL, Gee MS. Inflammatory bowel disease imaging: current practice and future directions. World J Gastroenterol. 2016;3:917–932.
   Google Scholar
• Nugent SG, Kumar D, Rampton DS, et al. Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs. Gut. 2001;4:571–577.
   Google Scholar
• Ko HS, Kim IS, Lee K, et al. Characterization of binding and phagocytosis of oxidatively damaged erythrocyte to macrophage. Korean J Intern Med. 2002;4:220–226.
   Google Scholar
• Mullin NP, Hall KT, Taylor ME. Characterization of ligand binding to a carbohydrate-recognition domain of the macrophage mannose receptor. J Biol Chem. 1994;45:28405–28413.
   Google Scholar
• Simpson DZ, Hitchen PG, Elmhirst EL, et al. Multiple interactions between pituitary hormones and the mannose receptor. Biochem J. 1999;343(2):403–411.
   Google Scholar
• Gazi U, Martinez-Pomares L. Influence of the mannose receptor in host immune responses. Immunobiology. 2009;7:554–561.
   Google Scholar
• Hu Z, Shi X, Yu B, et al. Structural insights into the pH-dependent conformational change and collagen recognition of the human mannose receptor. Structure. 2018;1:60–71.e63.
   Google Scholar
• Goswami S, Bajpai J, Bajpai AK. Calcium alginate nanocarriers as possible vehicles for oral delivery of insulin. J Exp Nanosci. 2014;4:337–356.
   Google Scholar
• Nishida K, Kuma A, Fumoto S, et al. Absorption characteristics of model compounds from the small intestinal serosal surface and a comparison with other organ surfaces. J Pharm Pharmacol. 2005;8:1073–1077.
   Google Scholar
• Zhang Y, Liu AT, Cornejo YR, et al. A systematic comparison of in vitro cell uptake and in vivo biodistribution for three classes of gold nanoparticles with saturated peg coatings. PLoS One. 2020;7:e0234916.
   Google Scholar
• Elci SG, Jiang Y, Yan B, et al. Surface charge controls the suborgan biodistributions of gold nanoparticles. ACS Nano. 2016;5:5536–5542.
   Google Scholar
• Mathies F, Steffens N, Kleinschmidt D, et al. Colitis promotes a pathological condition of the liver in the absence of Foxp3(+) regulatory T cells. J Immunol. 2018;12:3558–3568.
   Google Scholar
• Lee A, De Mei C, Fereira M, et al. Dexamethasone-loaded polymeric nanoconstructs for monitoring and treating inflammatory bowel disease. Theranostics. 2017;7(15):3653–3666.
   Google Scholar
• Wu Y, Briley K, Tao X. Nanoparticle-based imaging of inflammatory bowel disease. Wiley Interdiscipl Rev Nanomed Nanobiotechnol. 2016;2:300–315.
   Google Scholar
• Flecknell P. Replacement, reduction and refinement. Altex. 2002;2:73–78.
   Google Scholar